185 related articles for article (PubMed ID: 37347656)
1. Assessment of plasma soluble Tie-2 level to distinguish moyamoya disease from atherosclerotic cerebrovascular disease and predict postoperative neovascularization.
Chen T; Wei W; Zhang J; Yu J; Xu S; Wu D; Li X; Chen J
J Neurosurg; 2023 Dec; 139(6):1705-1714. PubMed ID: 37347656
[TBL] [Abstract][Full Text] [Related]
2. Expression of circulating vascular endothelial growth factor-antagonizing cytokines and vascular stabilizing factors prior to and following bypass surgery in patients with moyamoya disease.
He J; Wang R; Zhang D; Zhang Y; Zhang Q; Zhao J
Exp Ther Med; 2014 Jul; 8(1):302-308. PubMed ID: 24944638
[TBL] [Abstract][Full Text] [Related]
3. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
Nadar SK; Blann A; Beevers DG; Lip GY
J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
[TBL] [Abstract][Full Text] [Related]
4. Minimally invasive colorectal resection for cancer is associated with a short-lived decrease in soluble Tie-2 receptor levels, which may transiently inhibit VEGF-mediated angiogenesis (via altered blood levels of free Ang-1 and Ang-2).
Shantha Kumara HM; Grieco MJ; Yan X; Kalady MF; DiMaggio V; Kim DG; Hyman N; Feingold DL; Whelan RL
Surg Endosc; 2010 Oct; 24(10):2581-7. PubMed ID: 20354881
[TBL] [Abstract][Full Text] [Related]
5. Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure.
Chong AY; Caine GJ; Freestone B; Blann AD; Lip GY
J Am Coll Cardiol; 2004 Feb; 43(3):423-8. PubMed ID: 15013125
[TBL] [Abstract][Full Text] [Related]
6. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
Lip PL; Chatterjee S; Caine GJ; Hope-Ross M; Gibson J; Blann AD; Lip GY
Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
[TBL] [Abstract][Full Text] [Related]
7. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes.
Lee KW; Lip GY; Blann AD
Circulation; 2004 Oct; 110(16):2355-60. PubMed ID: 15302795
[TBL] [Abstract][Full Text] [Related]
8. Significance of Serum Angiopoietin-2 in Patients with Hemorrhage in Adult-Onset Moyamoya Disease.
Yu J; Huang K; Pan J; Shen J; Zhan R
Biomed Res Int; 2020; 2020():8209313. PubMed ID: 32802878
[TBL] [Abstract][Full Text] [Related]
9. Plasma markers of angiogenesis in pregnancy induced hypertension.
Nadar SK; Karalis I; Al Yemeni E; Blann AD; Lip GY
Thromb Haemost; 2005 Nov; 94(5):1071-6. PubMed ID: 16363251
[TBL] [Abstract][Full Text] [Related]
10. Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer.
Caine GJ; Stonelake PS; Lip GY; Blann AD
Cancer Lett; 2007 Apr; 248(1):131-6. PubMed ID: 16891056
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of angiogenic molecules in autoimmune thyroid diseases and their correlation with laboratory and clinical features.
Figueroa-Vega N; Sanz-Cameno P; Moreno-Otero R; Sánchez-Madrid F; González-Amaro R; Marazuela M
J Clin Endocrinol Metab; 2009 Apr; 94(4):1145-53. PubMed ID: 19141578
[TBL] [Abstract][Full Text] [Related]
12. Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2.
Gotsch F; Romero R; Kusanovic JP; Chaiworapongsa T; Dombrowski M; Erez O; Than NG; Mazaki-Tovi S; Mittal P; Espinoza J; Hassan SS
J Matern Fetal Neonatal Med; 2008 Jun; 21(6):389-402. PubMed ID: 18570117
[TBL] [Abstract][Full Text] [Related]
13. Circulating angiopoietin and Tie-2 levels in systemic sclerosis.
Dunne JV; Keen KJ; Van Eeden SF
Rheumatol Int; 2013 Feb; 33(2):475-84. PubMed ID: 22461185
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease.
Rafat N; Beck GCh; Peña-Tapia PG; Schmiedek P; Vajkoczy P
Stroke; 2009 Feb; 40(2):432-8. PubMed ID: 19095988
[TBL] [Abstract][Full Text] [Related]
15. Correlation Between Apelin and Collateral Circulation in Patients with Middle Cerebral Artery Occlusion and Moyamoya Disease.
Wu H; Xia C; Li R; Tao C; Tang Q; Hu W
Int J Gen Med; 2022; 15():699-709. PubMed ID: 35082519
[TBL] [Abstract][Full Text] [Related]
16. The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.
Mohan JS; Lip PL; Blann AD; Bareford D; Lip GY
Br J Ophthalmol; 2005 Jul; 89(7):815-9. PubMed ID: 15965157
[TBL] [Abstract][Full Text] [Related]
17. Differential Expression of Vascular Endothelial Growth Factor-A
Jiang H; Toscano JF; Schiraldi M; Song SS; Schlick KH; Dumitrascu OM; Liou R; Lyden PD; Pan J; Zhan R; Saver JL; Gonzalez NR
J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):360-368. PubMed ID: 30392834
[TBL] [Abstract][Full Text] [Related]
18. Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1.
Caine GJ; Blann AD; Stonelake PS; Ryan P; Lip GY
Eur J Clin Invest; 2003 Oct; 33(10):883-90. PubMed ID: 14511360
[TBL] [Abstract][Full Text] [Related]
19. Increased mRNA expression of VEGF within the hematoma and imbalance of angiopoietin-1 and -2 mRNA within the neomembranes of chronic subdural hematoma.
Hohenstein A; Erber R; Schilling L; Weigel R
J Neurotrauma; 2005 May; 22(5):518-28. PubMed ID: 15892598
[TBL] [Abstract][Full Text] [Related]
20. TGFβ1 as a Predictive Biomarker for Collateral Formation Within Ischemic Moyamoya Disease.
Chen Y; Tang M; Li H; Liu H; Wang J; Huang J
Front Neurol; 2022; 13():899470. PubMed ID: 35873760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
